BamSEC and AlphaSense Join Forces
Learn More

Sucampo Pharmaceuticals, Inc.

Formerly NASDAQ: SCMP
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 27 pages Second Amendment to Office Lease Agreement
12/34/56
EX-10.3
from 10-Q 16 pages Executive Employment Agreement
12/34/56
EX-10.2
from 10-Q 21 pages Separation Agreement and Releases
12/34/56
EX-10.1
from 10-Q 14 pages Confidential Separation Agreement and General Release This Separation Agreement and General Release (The “Separation Agreement”) Is Made by and Between Sucampo Pharmaceuticals, Inc., (“Spi”) and Andrew Smith (“Employee”). Whereas, Employee and Spi Are Parties to the Amended and Restated Executive Employment Agreement Attached as Exhibit 1 to This Separation Agreement (“Employment Agreement”);
12/34/56
EX-10.1
from 10-Q 17 pages Executive Employment Agreement
12/34/56
EX-10.45
from 10-K 7 pages Sucampo Pharmaceuticals, Inc. 2016 Equity Incentive Plan Employee Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.44
from 10-K 12 pages Sucampo Pharmaceuticals, Inc. Amended and Restated 2006 Employee Stock Purchase Plan Adopted by the Board of Directors: June 5, 2006 Approved by the Stockholders: September 5, 2006 Amendment and Restatement Approved by the Board: December 8, 2016
12/34/56
EX-10.6
from 10-Q 18 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.5
from 10-Q 17 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.4
from 10-Q 17 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.3
from 10-Q 17 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.2
from 10-Q 17 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 15 pages Indemnification Agreement
12/34/56
EX-10.1
from 10-Q 29 pages Sucampo Pharmaceuticals, Inc. 2016 Equity Incentive Plan Adopted by the Board of Directors: April 18, 2016 Approved by the Stockholders: June 2, 2016 Termination Date: April 18, 2026
12/34/56
EX-10.5
from 10-Q 64 pages Employment Agreement
12/34/56
EX-10.4
from 10-Q 15 pages Separation Agreement and Releases
12/34/56
EX-10.3
from 10-Q 43 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 28 pages Option and Collaboration Agreement
12/34/56
EX-10.1
from 10-Q 11 pages Convertible Promissory Note
12/34/56
EX-10.41
from 10-K 8 pages Basic Transaction Agreement Concerning Outsourced Manufacturing R-Tech Ueno, Ltd. Nissan Chemical Industries, Ltd. Confidential and Proprietary Confidential Treatment Has Been Requested for Portions of This Exhibit. the Copy Filed Herewith Omits the Information Subject to a Confidentiality Request. Omissions Are Designated [***]. a Complete Version of This Exhibit Has Been Filed Separately With the Securities and Exchange Commission. Basic Transaction Agreement Concerning Outsourced Manufacturing
12/34/56